ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000258303.1	Lenalidomide	Bladder urothelial carcinoma	0.022926782	Sensitive
ENSG00000258303.1	Lenalidomide	Breast invasive carcinoma	0.019107196	Sensitive